Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, September 22, 2022
Peli BioThermal extends service centers in Japan with a new facility, situated near Tokyo’s international Narita Airport.
read more
Thursday, September 22, 2022
Bora Pharmaceutical Labs, a division of Bora Pharmaceuticals, partnered with TaiRx, a Taiwanese drug development company, to manufacture a novel anticancer drug, CVM-1118.
read more
Wednesday, September 21, 2022
Alliance Pharma hired four new leaders, bringing on a new Chief Operating Officer (COO), Chief Commercial Officer (CCO), Chief Financial Officer (CFO), and Chief People Officer (CPO). These leaders will support continued global expansion, which ...
read more
Wednesday, September 21, 2022
WuXi Biologics announced that its two Drug Substance (DS) facilities and a Drug Product (DP) facility located in Wuxi city received regulatory approvals from the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA).
read more
Wednesday, September 21, 2022
Accumulus Synergy, a non-profit organization working to develop an information and data exchange platform aimed at transforming how life science innovators and health authorities worldwide interact, announced that Merck, known as MSD outside the ...
read more
Wednesday, September 21, 2022
Merck will initiate a new Phase 3 clinical program with once-daily islatravir for the treatment of people with HIV-1 infection.
read more
Wednesday, September 21, 2022
Lykan Bioscience named Barbara Ressler, Ph.D. VP of Manufacturing Process Sciences. development, process development and manufacturing science and technology (MS&T) teams.
read more
Wednesday, September 21, 2022
Johnson & Johnson opened its San Francisco Bay Campus, a state-of-the-art Research & Development (R&D) facility in the Bay Area, one of the world’s most established global hubs for innovation and entrepreneurship.
read more
Wednesday, September 21, 2022
Charles River Associates announced that Kenneth J. Beers has joined CRA as a Vice President in the Company’s Life Sciences Practice.
read more
Monday, September 19, 2022
LSPediA Inc., a cloud solutions provider for the pharmaceutical industry, added Patrick O'Donohue to its Leadership Team as Vice President of Operations.
read more
Thursday, September 15, 2022
Immunologix Laboratories announced that Dr. Pierre Jolicoeur has been appointed Chief Operating Officer. A seasoned scientist and trusted operational leader, Dr. Jolicoeur will help drive strategic growth and operational excellence across the company...
read more
Thursday, September 15, 2022
Fast-growing contract development and manufacturing organization (CDMO), Bora Pharmaceuticals, has completed the acquisition of TWi Pharmaceutical Co.Ltd, a technology-based company specializing in development and commercialization of niche generic ...
read more
Thursday, September 15, 2022
The development of new drug products and forms of therapy is progressing rapidly. For contract developers and manufacturers, this means staying on the cutting edge of production technologies and actively supporting customers with innovative ...
read more
Thursday, September 15, 2022
The PPD clinical research business of Thermo Fisher Scientific has been awarded a 10-year Indefinite-Delivery, Indefinite-Quantity (IDIQ) contract by the National Cancer Institute (NCI), part of the National Institutes of Health, to support NCI’s ...
read more
Wednesday, September 14, 2022
BioIVT, a provider of biospecimens, research models and services for drug and diagnostic development, has acquired XenoTech, a provider of products for ADME-Tox in vitro models and contract research services, from Sekisui Chemical, based in Japan. ...
read more